Skip to main content
Equibles

Man Group plc

Position in EBS — Emergent BioSolutions Inc.

CIK 1637460 LONDON, X0
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$557,496
+$182,336 QoQ
Shares Held
66,527
+47.2% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 194 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. EBS ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,805,003 $129,707,515
2 NBIX
Neurocrine Biosciences Inc
 601,019 $101,295,742
3 UTHR
UNITED THERAPEUTICS Corp
 134,890 $73,087,447
4 VTRS
Viatris Inc
 3,523,052 $55,946,065
5 PRGO
PERRIGO Co plc
 1,530,206 $15,898,840
6 BCRX
Biocryst Pharmaceuticals Inc
 732,867 $7,328,670
7 SUPN
Supernus Pharmaceuticals, Inc.
 156,422 $7,275,186
8 BHC
Bausch Health Companies Inc.
 1,451,781 $7,157,279

All Filings in EBS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $557,496 66,527
2026-03-31 $375,160 45,200
2025-09-30 $267,916 30,376
2025-06-30 $271,839 42,608
2025-03-31 $482,180 99,214
2024-12-31 $1,690,016 176,780
2023-12-31 $297,206 123,836
2023-09-30 $489,062 143,842
2023-06-30 $3,307,168 449,955
2023-03-31 $6,768,788 653,358
2022-12-31 $10,386,280 879,448
2022-09-30 $13,742,551 654,719
2022-06-30 $13,161,455 424,016
2022-03-31 $906,194 22,070
2021-09-30 $751,050 15,000
2021-06-30 $541,714 8,600
2021-03-31 $397,375 4,277
2020-12-31 $4,040,422 45,094
2020-09-30 $17,596,272 170,292
2020-06-30 $6,746,551 85,313
2020-03-31 $1,560,194 26,965